Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy

Neuro-Oncology

Volumn 6, Issue 2, 2004, Pages 113-118

  Xu, Weizhen ^a   Janns, Anna ^a   Packer, Roger J ^c   Phillips, Peter ^a   Goldwein, Joel ^b   Moshang Jr , Thomas ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; ESTROGEN; GONADORELIN AGONIST; RECOMBINANT GROWTH HORMONE; TESTOSTERONE;

ADRENAL INSUFFICIENCY; ANAMNESIS; ARTICLE; BODY HEIGHT; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; ENDOCRINE DISEASE; FEMALE; GROWTH RETARDATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; MALE; MEDULLOBLASTOMA; MORBIDITY; OUTCOMES RESEARCH; PRECOCIOUS PUBERTY; RADIATION DOSE; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT PLANNING;

ADOLESCENT; BODY HEIGHT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOCRINE SYSTEM; ENDOCRINE SYSTEM DISEASES; FEMALE; GAMMA RAYS; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; MALE; MEDULLOBLASTOMA; RETROSPECTIVE STUDIES;

EID: 1842431996     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1152851703000462     Document Type: Article

References (39)

1. Adan, L., Sainte-Rose, C., Souberbielle, J.C., Zucker, J.M., Kalifa, C., and Brauner, R. (2000) Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation. Med. Pediatr. Oncol. 34, 14-19.
2. Burns, E.C., Tanner, J.M., Preece, M.A., and Cameron, N. (1981) Growth hormone treatment in children with craniopharyngioma: Final growth status. Clin. Endocrinol. 14, 587-595.
3. CDC/NCHS. Centers for Disease Control, National Center for Health Statistics (2002) 2000 CDC Growth Charts: United States. Available at http://www.cdc.gov/growthcharts.
4. Clarson, C.L., and Del Maestro, R.F. (1999) Growth failure after treatment of pediatric brain tumors. Pediatrics 103, E37
5. Clayton, P.E., Shalet, S.M., Price, D.A., and Addison, G.M. (1988) Growth and growth hormone responses to oxandrolone in boys with constitutional delay of growth and puberty (CDGP). Clin. Endocrinol. 29, 123-130.
6. Collet-Solberg, P.F., Sernyak, H., Satin-Smith, M., Katz, L.L., Sutton, L., Molloy, P., and Moshang, T., Jr. (1997) Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma. Clin. Endocrinol. 47, 79-85.
7. Costin, G. (1988) Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary function. Am. J. Dis. Child. 142, 847-852.
8. Dacou-Voutetakis, C., Kitra, V., Grafakos, S., Polychronopoulou, S., Drakopoulou, M., and Haidas, S. (1993) Auxologic data and hormonal profile in long-term survivors of childhood acute lymphoid leukemia. Am. J. Pediatr Hematol. Oncol. 15, 277-283.
9. Dangour, A.D., Schilg, S., Hulse, J.A., and Cole, T.J. (2002) Sitting height and subischial leg length centile curves for boys and girls from Southeast England. Ann. Hum. Biol. 29, 290-305.
10. Darendeliler, F., Livesey, E.A., Hindmarsh, P.C., and Brook, C.G. (1990) Growth and growth hormone secretion in children following treatment of brain tumours with radiotherapy. Acta Paediatr. Scand. 79, 950-956.
11. Goldwein, J.W., Radcliffe, J., Packer, R.J., Sutton, L.N., Lange, B., Rorke, L.B., and D'Angio, G.J. (1993) Results of a pilot study of low-dose craniospinal radiation therapy plus chemotherapy for children younger than 5 years with primitive neuroectodermal tumors. Cancer 71, 2647-2652.
12. Goldwein, J.W., Radcliffe, J., Johnson, J., Moshang, T., Packer, R.J., Sutton, L.N., Rorke, L.B., and D'Angio, G.J. (1996). Updated results of a pilot study of low dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int. J. Radiat. Oncol. Biol. Phys. 34, 899-904.
13. Helseth, E., Due-Tonnessen, B., Wesenberg, F., Lote, K., and Lundar, T. (1999) Posterior fossa medulloblastoma in children and young adults (0-19 years): Survival and performance. Childs Nerv. Syst. 15, 451-455.
14. Kanev, P.M., Lefebvre, J.F., Mauseth, R.S., and Berger, M.S. (1991) Growth hormone deficiency following radiation therapy of primary brain tumors in children. J. Neurosurg. 74, 743-748.
15. Kiltie, A.E., Lashford, L.S., and Gattamaneni, H.R. (1997) Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med. Pediatr. Oncol. 28, 348-354.
16. Leiper, A.D. (1990) Management of growth failure in the treatment of malignant disease. Pediatr. Hematol. Oncol. 7, 365-371.
17. Marx, M., Schoof, E., Grabenbauer, G.G., Beck, J.D., and Doerr, H.G. (1999) Effects of puberty on bone age maturation in a girl after medulloblastoma therapy. J. Pediatr. Adolesc. Gynecol. 12, 62-66.
18. Merchant, T.E., Goloubeva, O., Pritchard, D.L., Gaber, M.W., Xiong, X., Danish, R.K., and Lustig, R.H. (2002) Radiation dose volume effects on growth hormone secretion. Int. J. Radiat. Oncol. Biol. Phys. 52, 1264-1270.
19. Moshang, T., (1997) Outcomes of pediatric brain tumors as related to growth and adolescent development. Curr. Opin. Endocrinol. Diabetes 4, 80-84.
20. Moshang, T., Jr., and Grimberg, A. (1996) The effects of irradiation and chemotherapy on growth. Endocrinol. Metab. Clin. North Am. 25, 731-741.
21. Noorda, E.M., Somers, R., van Leeuwen, F.E., Vulsma, T., and Behrendt, H. (2001) The Dutch Late Effects Study Group. Adult height and age at menarche in childhood cancer survivors. Eur. J. Cancer 37, 605-612.
22. Ogilvy-Stuart, A.L., and Shalet, S.M. (1995) Growth and puberty after growth hormone treatment after irradiation for brain tumors. Arch. Dis. Child. 73, 141-146.
23. Olshan, J.S., Gubernick, J., Packer, R.J., D'Angio, D.J., Goldwein, J.W., Willi, S.M., and Moshang, T., Jr. (1992) The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer 70, 2013-2017.
24. Packer, R.J., Goldwein, J., Nicholson, H.S., Vezina, L.G., Allen, J.C., Ris, M.D., Muraszko, K., Rorke, L.B., Wara, W.M., Cohen, B.H., and Boyett, J.M. (1999) Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group study. J. Clin. Oncol. 17, 2127-2136.
25. Packer, R.J., Boyett, J.M., Janss, A.J., Stavrou, T., Kun, L., Wisoff, J., Russo, C., Geyer, R., Phillips, P., Kieran, M., Greenberg, M., Goldman, S., Hyder, D., Heideman, R., Jones-Wallace, D., August, G.P., Smith, S.H., and Moshang, T., Jr. (2001) Growth hormone replacement therapy in children with medulloblastoma: Use and effect on tumor control. J. Clin. Oncol. 19, 480-487.
26. Probert, J.C., Lederman, M., and Bagshaw, M.A. (1973) Medulloblastoma - treatment and prognosis. A study of seventeen cases in ten years. Calif. Med. 118, 14-17.
27. Ranke, M.B., and Price, D.A. (1999) Growth hormone treatment in children with malignant cranial tumors in KIGS. In: Ranke, M.B., and Wilton, P. (Eds.) Growth Hormone Therapy in KIGS: 10 Years' Experience. Heidelberg: Johann Ambrosius Barth Verlag, 159-174.
28. Rappaport, R., and Brauner, R. (1989) Growth and endocrine disorders secondary to cranial irradiation. Pediatr. Res. 25, 561-567
29. Ricardi, U., Corrias, A., Einaudi, S., Genitori, L., Sandri, A., di Montezemolo, L.C., Besenzon, L., Madon, E., and Urgesi, A. (2001) Thyroid dysfunction as a late effect in childhood medulloblastoma: A comparison of hyperfractionated versus conventionally fractionated craniospinal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 50, 1287-1294.
30. Schmiegelow, M., Lassen, S., Poulsen, H.S., Feldt-Rasmussen, U., Schmiegelow, K., Hertz, H., and Muller, J. (2000) Cranial radiotherapy of childhood brain tumors: Growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study. Clin. Endocrinol. 53, 191-197.
31. Shalet, S.M. (1993) Radiation and pituitary dysfunction. N. Engl. J. Med. 328, 131-133 (letter, comment).
32. Shalet, S.M., and Brennan, B.M. (1998) Growth and growth hormone status following treatment for childhood leukaemia. Horm. Res. 50, 1-10.
33. Schriock, E.A., Schell, M.J., Carter, M., Hustu, O., and Ochs, J.J. (1991) Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J. Clin. Oncol. 9, 400-405.
34. Shalet, S.M., Beardwell, C.G., Twomey, J.A., Jones, P.H., and Pearson, D. (1977) Endocrine function following the treatment of acute leukemia in childhood. J. Pediatr 90, 920-923.
35. Shalet, S.M., Gibson, B., Swindell, R., and Pearson, D. (1987) Effect of spinal irradiation on growth. Arch. Dis. Child. 62, 461-464.
36. Shalet, S.M., Crowne, E.C., Didi, M.A., Ogilvy-Stuart, A.L., and Wallace, W.H. (1992) Irradiation-induced growth failure. Baillieres Clin. Endocrinol. Metab. 6, 513-526.
37. Sulmont, V., Brauner, R., Fontoura, M., and Rappaport, R. (1990) Response to growth hormone treatment and final height after cranial or craniospinal irradiation. Acta Paediatr. Scand. 79, 542-549.
38. Thomas, P.R., Deutsch, M., Kepner, J.L., Boyett, J.M., Krischer, J., Aronin, P., Albright, L., Allen, J.C., Packer, R.J., Linggood, R., Mulhern, R., Stehbens, J.A., Langston, J., Stanley, P., Duffner, P., Rorke, L., Cherlow, J., Friedman, H.S., Finlay, J.L., Vietti, T.J., and Kun, L.E. (2000) Low-stage medulloblastoma: Final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J. Clin. Oncol. 18, 3004-3011.
39. Whelan, H.T., Krouwer, H.G., Schmidt, M.H., Reichert, K.W, and Kovnar, E.H. (1998) Current therapy and new perspectives in the treatment of medulloblastoma. Pediatr. Neurol. 18, 103-115.